((4R,7S,10S,13S,16S)-20-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-prolyl-L-arginylglycine; ((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-L-prolyl-L-arginylglycine; (Arg8)-Vasopressin
Gly-OH Vasopressin (TFA Salt) is a fully characterized chemical compound used as a reference standard of API Vasopressin. The standard offered is compliant with regulatory guidelines. Gly-OH Vasopressin (TFA Salt) is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
![Picture of [D-Asn]Vasopressin (TFA Salt)](https://bc3c83a0874864a50753-7010fd7f2bdf81ab41ee28479491701e.ssl.cf2.rackcdn.com/media//catalog/AR-V06152.jpg?size=256 "Show details for [D-Asn]Vasopressin (TFA Salt)")
